VERU-111 in the Treatment of SARS-Cov-2 Infection by Assessing Its Effect on the Proportion of Patients Who Die on Study

NCT04842747 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
204
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Veru Inc.